1. Home
  2. CAAS vs CLNN Comparison

CAAS vs CLNN Comparison

Compare CAAS & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CAAS

China Automotive Systems Inc.

N/A

Current Price

$4.21

Market Cap

130.6M

ML Signal

N/A

Logo Clene Inc.

CLNN

Clene Inc.

N/A

Current Price

$5.52

Market Cap

48.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CAAS
CLNN
Founded
N/A
2012
Country
China
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
130.6M
48.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CAAS
CLNN
Price
$4.21
$5.52
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$32.67
AVG Volume (30 Days)
25.7K
57.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$82.05
P/E Ratio
$3.97
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.50
$2.28
52 Week High
$5.37
$13.50

Technical Indicators

Market Signals
Indicator
CAAS
CLNN
Relative Strength Index (RSI) 37.47 58.80
Support Level $4.13 $3.43
Resistance Level $4.44 $5.71
Average True Range (ATR) 0.15 0.43
MACD -0.03 0.10
Stochastic Oscillator 12.50 92.50

Price Performance

Historical Comparison
CAAS
CLNN

About CAAS China Automotive Systems Inc.

China Automotive Systems Inc is a holding company. The firm through its subsidiary is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series, models of power steering including rack and pinion power steering, integral power steering, electronic power steering and manual steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Share on Social Networks: